These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38873617)

  • 1. Prevalence and effect of
    Ghosh A; Moorthy A
    Saudi J Biol Sci; 2024 Aug; 31(8):104029. PubMed ID: 38873617
    [No Abstract]   [Full Text] [Related]  

  • 2. PIK3CA mutations in head and neck squamous cell carcinoma.
    Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
    Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
    Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
    Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive detection of the PIK3CA (H1047R) mutation in colorectal cancer using a novel PCR-RFLP method.
    Li WM; Hu TT; Zhou LL; Feng YM; Wang YY; Fang J
    BMC Cancer; 2016 Jul; 16():454. PubMed ID: 27405731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.
    Theurer JA; Stecho W; Yoo J; Kwan K; Wehrli B; Harry V; Black M; Pinto N; Winquist E; Palma D; Richter S; Barrett JW; Danielle MacNeil S; Fung K; Howlett CJ; Nichols AC
    Pathol Oncol Res; 2016 Jan; 22(1):35-40. PubMed ID: 26271341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.
    Wirtz ED; Hoshino D; Maldonado AT; Tyson DR; Weaver AM
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):543-9. PubMed ID: 25855885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Arg399Gln single-nucleotide polymorphism in
    Dutta D; Abarna R; Shubham M; Subbiah K; Duraisamy S; Chinnusamy R; Anbalagan M
    J Cancer Res Ther; 2020; 16(3):551-558. PubMed ID: 32719266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer.
    Schmidt H; Kulasinghe A; Allcock RJN; Tan LY; Mokany E; Kenny L; Punyadeera C
    Diagnostics (Basel); 2018 Nov; 8(4):. PubMed ID: 30501041
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    García-Carracedo D; Cai Y; Qiu W; Saeki K; Friedman RA; Lee A; Li Y; Goldberg EM; Stratikopoulos EE; Parsons R; Lu C; Efstratiadis A; Philipone EM; Yoon AJ; Su GH
    Mol Cancer Res; 2020 Jun; 18(6):822-834. PubMed ID: 32152233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of
    Borkowska EM; Barańska M; Kowalczyk M; Pietruszewska W
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population.
    Kumar R; Kumar R; Goel H; Kumar S; Ningombam SS; Haider I; Agrawal U; Deo S; Gogia A; Batra A; Sharma A; Mathur S; Ranjan A; Chopra A; Hussain S; Tanwar P
    Cancer Cell Int; 2023 Oct; 23(1):236. PubMed ID: 37821962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
    Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
    BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
    Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
    Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.
    Guo S; Loibl S; von Minckwitz G; Darb-Esfahani S; Lederer B; Denkert C
    Cancer Res Treat; 2020 Jul; 52(3):689-696. PubMed ID: 32019278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand.
    Dechaphunkul A; Thongwatchara P; Thongsuksai P; Dechaphunkul T; Geater SL
    J Pathol Transl Med; 2022 May; 56(3):126-133. PubMed ID: 35209701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study.
    Yi Z; Ma F; Liu B; Guan X; Li L; Li C; Qian H; Xu B
    BMC Cancer; 2019 May; 19(1):442. PubMed ID: 31088410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
    Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
    Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.
    Baba Y; Maeda T; Suzuki A; Takada S; Fujii M; Kato Y
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma.
    McBride SM; Rothenberg SM; Faquin WC; Chan AW; Clark JR; Ellisen LW; Wirth LJ
    Head Neck; 2014 Aug; 36(8):1181-8. PubMed ID: 23852799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression.
    Trejo CL; Green S; Marsh V; Collisson EA; Iezza G; Phillips WA; McMahon M
    Cancer Res; 2013 Nov; 73(21):6448-61. PubMed ID: 24019382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.